Bluejay Diagnostics Inc. Revenue 2022–2022
Bluejay Diagnostics Inc. annual/quarterly revenue history and growth rate from 2022 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bluejay Diagnostics Inc. revenue for the quarter ending June 30, 2022 was 249040.
- Bluejay Diagnostics Inc. annual revenue for 2022 was 249040.
Bluejay Diagnostics Inc. (BJDX) — Frequently Asked Questions
Bluejay Diagnostics Inc. (BJDX) is a publicly traded US company. It has a market capitalization of $5M. In fiscal 2022 it reported revenue of $249,040 and net income of -$9M. Explore BJDX's stock price, financial statements, earnings history, margins and key ratios below.
What is Bluejay Diagnostics Inc.'s market cap?
Bluejay Diagnostics Inc. (BJDX) has a market capitalization of $5M.
What is the BJDX stock price?
BJDX trades at $4.49 (-0.22% on the day).
How much revenue does Bluejay Diagnostics Inc. make?
Bluejay Diagnostics Inc. reported revenue of $249,040 in fiscal 2022.
Is BJDX profitable?
In fiscal 2022, Bluejay Diagnostics Inc. reported net income of -$9M.